Pilot & Feasibility Program

项目总结（试点和可行性研究） 该计划的目标是为符合科学重点的创新项目提供资金。 消化和肝脏疾病分子研究中心（CMSDLD）。我们取得了很大的成功， 与其他宾州中心/研究所/费城儿童医院合作，进行联合RFA， 为获奖者提供了更多的资助。此外，我们致力于支持新的 研究人员，包括年轻的科学家和那些以前没有从事消化系统研究的人， 或肝脏疾病。试点和可行性资助计划的预期成果是新的R 01资助 提案（和同等提案，例如VA Merit补助金），新的跨学科补助金提案（例如NIH U 01/U 54，P01， P50机制）和新的重要私人基金会/国家学会赠款提案。事实上，我们的飞行员和 可行性赠款方案在新赠款方面的投资回报率令人印象深刻，超过10：1。这是 通过科学的核心设施，结构化的导师计划， 深信扩大校园范围和国家事业的收件人，并促进学术 受助人的晋升。该计划的结构是包容整个大学的科学家 宾夕法尼亚重要的是，我们有一个强大的跟踪记录，确定年轻的科学家谁是妇女和 代表多样性和包容性，符合我们中心的理念和愿景。

PROJECT SUMMARY (PILOT & FEASIBILITY PROGRAM) The goal of this program is to provide funding for innovative projects compatible with the scientific focus of the Center for Molecular Studies in Digestive and Liver Diseases (CMSDLD). We have had high success in collaborations with other Penn Centers/Institutes/Children's Hospital of Philadelphia for joint RFAs that have served to increase funding for awardees in a significant fashion. Furthermore, we strive to support new investigators, including both young scientists and those who have not previously pursued research in digestive or liver diseases. The desired outcomes of the Pilot and Feasibility Grant Program are new R01 grant proposals (and equivalent, e.g. VA Merit grant), new interdisciplinary grant proposals (e.g. NIH U01/U54, P01, P50 mechanisms) and new significant private foundation/national society grant proposals. Indeed, our pilot and feasibility grant program has had an impressive return of investment in new grants, exceeding 10:1. This is complemented by a vast array of support through scientific core facilities, structured mentorship programs, and deep conviction to augment the campus wide and national careers of recipients, and facilitate the academic promotions of recipients. This program is structured to be inclusive of scientists throughout the University of Pennsylvania. Importantly, we have a robust track record of identifying young scientists who are women and represent diversity and inclusion, consistent with our Center's philosophy and vision.